THOUSAND OAKS, Calif., Nov. 7, 2023 /PRNewswire/ — Concept Matrix Solutions, Inc. (“CMS”) or the (“Company”), a privately held vertically integrated biotechnology company dedicated to developing and manufacturing innovative delivery forms in both pharmaceutical and nutraceutical spaces today announced that it has closed a private investment with Impact Biotech, LLC (“Impact”) for the purchase of 8.74% of post money equity. The gross proceeds of the private investment were $1.2 million. Impact Biotech will have an advisory seat on the board of Concept Matrix Solutions, Inc.
Since its formation in 2013, CMS has been an industry leader in developing novel therapeutic dose forms with complex molecules that span the health & wellness industry. CMS intends to use the proceeds from the financing to promote aggressive growth in its IP portfolio and increase research and development…
